Improving access for anti-tumour necrosis factor-a therapy in inflammatory bowel disease.
Biehl
Nicholas A
NA
Pawlik
Janina
J
Forbes
Geoffrey M
GM
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001315:Australia; D003424:Crohn Disease / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D007356:Insurance, Pharmaceutical Services; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab